Cornercap Investment Counsel’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
SCM
RCMC
BCM
RIM
Cornercap Investment Counsel's IRMD Position: Q1 2024 in Review
Cornercap Investment Counsel sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 24,396 shares — an estimated $1.16M sold.
Cornercap Investment Counsel first reported a position in IRMD in Q2 2022 and held it in 7 quarters. The position peaked at $1.46M in Q1 2023. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.
- Cornercap Investment Counsel reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
- Cornercap Investment Counsel sold 24,396 iRadimed shares in Q1 2024, an estimated $1.16M.
- Cornercap Investment Counsel first reported a position in iRadimed in Q2 2022 and held it in 7 quarters.
- Cornercap Investment Counsel's iRadimed position peaked at $1.46M in Q1 2023.
- 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.
Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.